Critical evaluation of a cost-effectiveness analysis;Kritische beurteilung einer kosteneffektivitäts-analyse

Praxis

Volumn 87, Issue 49, 1998, Pages 1695-1702

  Sendi, P P ^a   Bucher, H C ^a   Steurer, J ^b  

^a KANTONSSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN;

ADULT; AGED; ARTICLE; BLOOD; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; HUMAN; HYPOTHYROIDISM; MALE; MASS SCREENING; MIDDLE AGED; PUBLIC HEALTH; QUALITY ADJUSTED LIFE YEAR; SWITZERLAND;

ADULT; AGED; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; HYPOTHYROIDISM; MALE; MASS SCREENING; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; QUALITY-ADJUSTED LIFE YEARS; SWITZERLAND; THYROTROPIN;

EID: 6244288160     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Falkenberg M., Kagedal D., Norr A.: Screening of an elderly female population for hypo- and hyperthyroidism by use of a thyroid hormone panel. Acta Med Scand 1983; 214: 361-5.
2. Parle J.V., Franklyn J.A., Cross K.W., Jones S.C., Sheppard M.C.: Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf) 1991; 34: 77-83.
3. Nystrom E., Bengtsson C., Lindquist O., Noppa H., Lindstedt G., Lundberg P.A.: Thyroid disease and high concentration of serum thyrotrophin in a population sample of women. A 4-year follow-up. Acta Med Scand 1981; 210: 39-46.
4. Sawin C.T., Castelli W.P., Hershman J.M., McNamara P., Bacharach P.: The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med 1985; 145: 1386-8.
5. US Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed., Baltimore, Williams & Wilkins, 1996.
6. Danese M.D., Powe N.R., Sawin C.T., Ladenson P.W.: Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis. JAMA 1996; 276: 285-92.
7. Drummond M.F., Richardson W.S., O'Brien B.J., Levine M., Heyland D.: Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A . Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 1997; 277: 1552-7.
8. O'Brien B.J., Heyland D., Richardson W.S., Levine M., Drummond M. F.: Users' guides to the medical literature. XIII. How to use an article on economis analysis of clinical practice. B. What are the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. JAMA 1997; 277: 1802-6.
9. Russell L.B., Gold M.R., Siegel J.E., Daniels N., Weinstein M.C.: The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996; 276: 1172-7.
10. Weinstein M.C., Siegel J.E., Gold M.R., Kamlet M.S., Russell L.B.: Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 1996; 276: 1253-8.
11. Siegel J.E., Weinstein M.C., Russell L.B., Gold M.R.: Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996; 276: 1339-41.
12. Weinstein M.C., Stason W.B.: Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977; 296: 716-21.
13. Schulman K.A., Lynn L.A., Glick H.A., Eisenberg J.M.: Cost effectiveness of low-dose zidovudine therapy for asymptomatic patients with human immunodeficiency virus (HIV) infection. Ann Intern Med 1991; 114: 798-802.
14. Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Concorde Coordinating Committee. Lancet 1994; 343: 871-81.
15. Detsky A.S., Naglie I.G.: A clinician's guide to cost-effectiveness analysis. Ann Intern Med 1990; 113: 147-54.
16. Krumholz H.M., Cohen B.J., Tsevat J., Pasternak R.C., Weinstein M.C.: Cost-effectiveness of a smoking cessation program after myocardial infarction. J Am Coll Cardiol 1993; 22: 1697-702.
17. Oster G., Epstein A.M.: Cost-effectiveness of antihyperlipemic therapy in the prevention of coronary heart disease. The case of cholestyramine. JAMA 1987; 258: 2381-7.
18. Sisk J.E., Moskowitz M.D., Whang W., Lin J.D., Fedson D.S., McBean A.M., Plouffe J.F., Cetron M.S., Butler J.C.: Cost-effectiveness of Vaccination Against Pneumococcal Bacteriemia Among Elderly People. JAMA 1997; 278: 1333-9.